We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$369M
AUM Growth
+$18.1M
Cap. Flow
-$6.35M
Cap. Flow %
-1.72%
Top 10 Hldgs %
45.57%
Holding
168
New
3
Increased
14
Reduced
34
Closed
2

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$378K
2
LLY icon
Eli Lilly
LLY
+$252K
3
MDT icon
Medtronic
MDT
+$175K
4
GILD icon
Gilead Sciences
GILD
+$170K
5
INTC icon
Intel
INTC
+$159K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$952K
2
V icon
Visa
V
+$431K
3
ROP icon
Roper Technologies
ROP
+$337K
4
ALB icon
Albemarle
ALB
+$296K
5
IQV icon
IQVIA
IQV
+$285K

Sector Composition

Rank Sector Weight
1 Technology 31.9%
2 Healthcare 14.1%
3 Financials 12.95%
4 Communication Services 11.09%
5 Consumer Staples 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$335B
$4.08M 1.11%
27,439
+230
+0.8% +$32.9K
CSCO icon
27
Cisco
CSCO
$486B
$3.88M 1.05%
74,252
CVX icon
28
Chevron
CVX
$386B
$3.68M 1%
22,552
+35
+0.2% +$5.87K
AFL icon
29
Aflac
AFL
$60.4B
$3.63M 0.98%
56,290
-800
-1% -$54.8K
HXL icon
30
Hexcel
HXL
$7.65B
$3.16M 0.86%
46,275
-80
-0.2% -$5.43K
MSFT icon
31
Microsoft
MSFT
$3.67T
$2.64M 0.72%
9,155
CRM icon
32
Salesforce
CRM
$158B
$2.22M 0.6%
11,125
WWD icon
33
Woodward
WWD
$21.2B
$2.15M 0.58%
22,080
-475
-2% -$47.8K
ABBV icon
34
AbbVie
ABBV
$441B
$2.11M 0.57%
13,218
RITM.PRB icon
35
Rithm Capital Corp 7.125% Series B Preferred Stock
RITM.PRB
$284M
$1.63M 0.44%
76,883
JPM icon
36
JPMorgan Chase
JPM
$970B
$1.62M 0.44%
12,460
-40
-0.3% -$5.48K
WFC.PRL icon
37
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.31M 0.35%
1,134
SHEL icon
38
Shell
SHEL
$248B
$1.29M 0.35%
22,456
VRSN icon
39
VeriSign
VRSN
$25.6B
$1.27M 0.34%
5,995
EW icon
40
Edwards Lifesciences
EW
$53.3B
$1.16M 0.31%
14,040
-885
-6% -$69.6K
GILD icon
41
Gilead Sciences
GILD
$169B
$990K 0.27%
11,931
+2,050
+21% +$170K
DOW icon
42
Dow Inc
DOW
$22.2B
$973K 0.26%
17,747
+2,200
+14% +$124K
SCHW
43
Charles Schwab
SCHW
$187B
$894K 0.24%
17,068
MCD icon
44
McDonald's
MCD
$194B
$733K 0.2%
2,622
+397
+18% +$106K
PFE icon
45
Pfizer
PFE
$150B
$719K 0.19%
17,623
AGNCO icon
46
AGNC Investment Dep Shares 1/1000 Cumulative Series E
AGNCO
$695K 0.19%
34,367
T.PRA icon
47
AT&T Series A
T.PRA
$856M
$674K 0.18%
30,200
+2,100
+7% +$44.6K
AVY icon
48
Avery Dennison
AVY
$13.6B
$644K 0.17%
3,600
-100
-3% -$18.2K
ABT icon
49
Abbott
ABT
$190B
$614K 0.17%
6,060
VZ icon
50
Verizon
VZ
$195B
$612K 0.17%
15,745

Similar funds

Kelly Lawrence W & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Kelly Lawrence W & Associates held 168 positions worth $369M, up 5.2% from $351M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 3%. Kelly Lawrence W & Associates opened 3 new positions and exited 2, leaving the 168-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Kelly Lawrence W & Associates's largest Q1 2023 buy was Eli Lilly: 747 shares worth $257K.
  • Kelly Lawrence W & Associates added most to American Tower in Q1 2023, an estimated $378K increase.
  • Kelly Lawrence W & Associates's biggest Q1 2023 reduction was Apple, cutting an estimated $952K.
  • Kelly Lawrence W & Associates fully exited Walmart Inc in Q1 2023, selling an estimated $105K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 46% of its $369M portfolio in Q1 2023.
  • Kelly Lawrence W & Associates opened 3 new positions and closed 2 in Q1 2023.
  • Kelly Lawrence W & Associates's portfolio value rose 5.2% quarter-over-quarter to $369M.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2023, filed 15 May 2023.